APO Research
Talk to an analyst

APO RESEARCH · REPORT

In Vitro Diagnostic (IVD) Reagents

In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.

Selected research

Market Outlook & Growth Opportunities

Global In Vitro Diagnostic (IVD) Reagents Market Outlook and Growth Opportunities 2026

28 December 2025204 pages

Choose your research edition.

Industry ResearchIn Vitro Diagnostic (IVD) Reagents Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal In Vitro Diagnostic (IVD) Reagents Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal In Vitro Diagnostic (IVD) Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In Vitro Diagnostic (IVD) Reagents Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal In Vitro Diagnostic (IVD) Reagents Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.

Global In Vitro Diagnostic (IVD) Reagents key players include Roche, Danaher, Sysmex Corporation, Mindray Medical, etc. Global top four manufacturers hold a share over 20%.

North America is the largest market, with a share about 40%, followed by Europe, and Japan, both have a share over 35 percent.

Read the full market overview

In terms of product, POCT is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital, followed by Laboratory, etc.

This report provides an overview of the global In Vitro Diagnostic (IVD) Reagents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In Vitro Diagnostic (IVD) Reagents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In Vitro Diagnostic (IVD) Reagents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the In Vitro Diagnostic (IVD) Reagents market size, projected growth trends, production technologies, key applications, and end-use industries.

In Vitro Diagnostic (IVD) Reagents Segment by Company

Roche

Danaher

Abbott Laboratories

Thermal Fisher

Sysmex Corporation

Biomerieux

Siemens

Ortho Clinical Diagnostics

BD

Bio-Rad

Myriad Genetics

Hologic

QIAGEN

Mindray Medical

Wondfo

KHB

Da An Gene

Leadman

Biosino

In Vitro Diagnostic (IVD) Reagents Segment by Type

Immune Diagnosis

Clinical and Biochemical

Molecular Diagnosis

POCT

Other

In Vitro Diagnostic (IVD) Reagents Segment by Application

Hospital

Laboratory

Other

In Vitro Diagnostic (IVD) Reagents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global In Vitro Diagnostic (IVD) Reagents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions In Vitro Diagnostic (IVD) Reagents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify In Vitro Diagnostic (IVD) Reagents significant trends, drivers, influence factors in global and regions.

6. To analyze In Vitro Diagnostic (IVD) Reagents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic (IVD) Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic (IVD) Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic (IVD) Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the In Vitro Diagnostic (IVD) Reagents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vitro Diagnostic (IVD) Reagents industry.

Chapter 3: Detailed analysis of In Vitro Diagnostic (IVD) Reagents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of In Vitro Diagnostic (IVD) Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of In Vitro Diagnostic (IVD) Reagents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. In Vitro Diagnostic (IVD) Reagents Industry Trends Table 2. In Vitro Diagnostic (IVD) Reagents Industry Drivers Table 3. In Vitro Diagnostic (IVD) Reagents Industry Opportunities and Challenges Table 4. In Vitro Diagnostic (IVD) Reagents Industry Restraints Table 5. Global In Vitro Diagnostic (IVD) Reagents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global In Vitro Diagnostic (IVD) Reagents Revenue Share by Company (2021-2026) Table 7. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Company (Million Units) & (2021-2026) Table 8. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Company (2021-2026) Table 9. Global In Vitro Diagnostic (IVD) Reagents Average Price (US$/Unit) of Company (2021-2026) Table 10. Global In Vitro Diagnostic (IVD) Reagents Company Ranking, (2024-2026) & (USD Million) Table 11. Global In Vitro Diagnostic (IVD) Reagents Key Company Manufacturing Base & Headquarters Table 12. Global In Vitro Diagnostic (IVD) Reagents Company, Product Type & Application Table 13. Global In Vitro Diagnostic (IVD) Reagents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global In Vitro Diagnostic (IVD) Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immune Diagnosis Table 18. Significant Companies of Clinical and Biochemical Table 19. Significant Companies of Molecular Diagnosis Table 20. Significant Companies of POCT Table 21. Significant Companies of Other Table 22. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type 2021 VS 2025 VS 2032 (Million Units) Table 23. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type (2021-2026) & (Million Units) Table 24. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type (2027-2032) & (Million Units) Table 25. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Type (2021-2026) Table 26. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Type (2027-2032) Table 27. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type (2021-2026) Table 31. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Laboratory Table 34. Significant Companies of Other Table 35. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application 2021 VS 2025 VS 2032 (Million Units) Table 36. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application (2021-2026) & (Million Units) Table 37. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application (2027-2032) & (Million Units) Table 38. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Application (2021-2026) Table 39. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Application (2027-2032) Table 40. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application (2021-2026) Table 44. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application (2027-2032) Table 45. Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2021 VS 2025 VS 2032 (Million Units) Table 46. Global In Vitro Diagnostic (IVD) Reagents Sales by Region (2021-2026) & (Million Units) Table 47. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region (2021-2026) Table 48. Global In Vitro Diagnostic (IVD) Reagents Sales by Region (2027-2032) & (Million Units) Table 49. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region (2027-2032) Table 50. Global In Vitro Diagnostic (IVD) Reagents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Region (2021-2026) Table 53. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Region (2027-2032) Table 55. Global In Vitro Diagnostic (IVD) Reagents Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global In Vitro Diagnostic (IVD) Reagents Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global In Vitro Diagnostic (IVD) Reagents Sales by Country: 2021 VS 2025 VS 2032 (Million Units) Table 58. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2026) & (Million Units) Table 60. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Country (2021-2026) Table 61. Global In Vitro Diagnostic (IVD) Reagents Sales by Country (2027-2032) & (Million Units) Table 62. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Country (2027-2032) Table 63. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global In Vitro Diagnostic (IVD) Reagents Sales Value Market Share by Country (2021-2026) Table 65. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global In Vitro Diagnostic (IVD) Reagents Sales Value Market Share by Country (2027-2032) Table 67. Roche Company Information Table 68. Roche Business Overview Table 69. Roche In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Roche In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 71. Roche Recent Development Table 72. Danaher Company Information Table 73. Danaher Business Overview Table 74. Danaher In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Danaher In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 76. Danaher Recent Development Table 77. Abbott Laboratories Company Information Table 78. Abbott Laboratories Business Overview Table 79. Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 81. Abbott Laboratories Recent Development Table 82. Thermal Fisher Company Information Table 83. Thermal Fisher Business Overview Table 84. Thermal Fisher In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Thermal Fisher In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 86. Thermal Fisher Recent Development Table 87. Sysmex Corporation Company Information Table 88. Sysmex Corporation Business Overview Table 89. Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 91. Sysmex Corporation Recent Development Table 92. Biomerieux Company Information Table 93. Biomerieux Business Overview Table 94. Biomerieux In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Biomerieux In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 96. Biomerieux Recent Development Table 97. Siemens Company Information Table 98. Siemens Business Overview Table 99. Siemens In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Siemens In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 101. Siemens Recent Development Table 102. Ortho Clinical Diagnostics Company Information Table 103. Ortho Clinical Diagnostics Business Overview Table 104. Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 106. Ortho Clinical Diagnostics Recent Development Table 107. BD Company Information Table 108. BD Business Overview Table 109. BD In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. BD In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 111. BD Recent Development Table 112. Bio-Rad Company Information Table 113. Bio-Rad Business Overview Table 114. Bio-Rad In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Bio-Rad In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 116. Bio-Rad Recent Development Table 117. Myriad Genetics Company Information Table 118. Myriad Genetics Business Overview Table 119. Myriad Genetics In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Myriad Genetics In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 121. Myriad Genetics Recent Development Table 122. Hologic Company Information Table 123. Hologic Business Overview Table 124. Hologic In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Hologic In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 126. Hologic Recent Development Table 127. QIAGEN Company Information Table 128. QIAGEN Business Overview Table 129. QIAGEN In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. QIAGEN In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 131. QIAGEN Recent Development Table 132. Mindray Medical Company Information Table 133. Mindray Medical Business Overview Table 134. Mindray Medical In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Mindray Medical In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 136. Mindray Medical Recent Development Table 137. Wondfo Company Information Table 138. Wondfo Business Overview Table 139. Wondfo In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Wondfo In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 141. Wondfo Recent Development Table 142. KHB Company Information Table 143. KHB Business Overview Table 144. KHB In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. KHB In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 146. KHB Recent Development Table 147. Da An Gene Company Information Table 148. Da An Gene Business Overview Table 149. Da An Gene In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Da An Gene In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 151. Da An Gene Recent Development Table 152. Leadman Company Information Table 153. Leadman Business Overview Table 154. Leadman In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Leadman In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 156. Leadman Recent Development Table 157. Biosino Company Information Table 158. Biosino Business Overview Table 159. Biosino In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Biosino In Vitro Diagnostic (IVD) Reagents Product Portfolio Table 161. Biosino Recent Development Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. In Vitro Diagnostic (IVD) Reagents Distributors List Table 165. In Vitro Diagnostic (IVD) Reagents Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. In Vitro Diagnostic (IVD) Reagents Product Image Figure 2. Global In Vitro Diagnostic (IVD) Reagents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032) & (US$ Million) Figure 4. Global In Vitro Diagnostic (IVD) Reagents Sales (2021-2032) & (Million Units) Figure 5. Global In Vitro Diagnostic (IVD) Reagents Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global In Vitro Diagnostic (IVD) Reagents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immune Diagnosis Image Figure 10. Clinical and Biochemical Image Figure 11. Molecular Diagnosis Image Figure 12. POCT Image Figure 13. Other Image Figure 14. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type (2021 VS 2025 VS 2032) & (Million Units) Figure 15. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Type (2021-2032) Figure 17. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Laboratory Image Figure 22. Other Image Figure 23. Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application (2021 VS 2025 VS 2032) & (Million Units) Figure 24. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Application (2021-2032) Figure 26. Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application (2021-2032) Figure 29. Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2021 VS 2025 VS 2032 (Million Units) Figure 30. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global In Vitro Diagnostic (IVD) Reagents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032) & (US$ Million) Figure 34. North America In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032) & (US$ Million) Figure 36. Europe In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032) & (US$ Million) Figure 40. South America In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. In Vitro Diagnostic (IVD) Reagents Value Chain Figure 128. Manufacturing Cost Structure Figure 129. In Vitro Diagnostic (IVD) Reagents Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Diagnosis
  • Clinical and Biochemical
  • Molecular Diagnosis
  • POCT
  • Other
Applications
  • Hospital
  • Laboratory
  • Other
Companies covered
  • Roche
  • Danaher
  • Abbott Laboratories
  • Thermal Fisher
  • Sysmex Corporation
  • Biomerieux
  • Siemens
  • Ortho Clinical Diagnostics
  • BD
  • Bio-Rad
  • Myriad Genetics
  • Hologic
  • QIAGEN
  • Mindray Medical
  • Wondfo
  • KHB
  • Da An Gene
  • Leadman
  • Biosino

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032)
  4. 1.2.2 Global In Vitro Diagnostic (IVD) Reagents Sales Volume (2021-2032)
  5. 1.2.3 Global In Vitro Diagnostic (IVD) Reagents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 In Vitro Diagnostic (IVD) Reagents Market Dynamics
  1. 2.1 In Vitro Diagnostic (IVD) Reagents Industry Trends
  2. 2.2 In Vitro Diagnostic (IVD) Reagents Industry Drivers
  3. 2.3 In Vitro Diagnostic (IVD) Reagents Industry Opportunities and Challenges
  4. 2.4 In Vitro Diagnostic (IVD) Reagents Industry Restraints
3 In Vitro Diagnostic (IVD) Reagents Market by Company
  1. 3.1 Global In Vitro Diagnostic (IVD) Reagents Company Revenue Ranking in 2025
  2. 3.2 Global In Vitro Diagnostic (IVD) Reagents Revenue by Company (2021-2026)
  3. 3.3 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Company (2021-2026)
  4. 3.4 Global In Vitro Diagnostic (IVD) Reagents Average Price by Company (2021-2026)
  5. 3.5 Global In Vitro Diagnostic (IVD) Reagents Company Ranking (2024-2026)
  6. 3.6 Global In Vitro Diagnostic (IVD) Reagents Company Manufacturing Base and Headquarters
  7. 3.7 Global In Vitro Diagnostic (IVD) Reagents Company Product Type and Application
  8. 3.8 Global In Vitro Diagnostic (IVD) Reagents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global In Vitro Diagnostic (IVD) Reagents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 In Vitro Diagnostic (IVD) Reagents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 In Vitro Diagnostic (IVD) Reagents Market by Type
  1. 4.1 In Vitro Diagnostic (IVD) Reagents Type Introduction
  2. 4.1.1 Immune Diagnosis
  3. 4.1.2 Clinical and Biochemical
  4. 4.1.3 Molecular Diagnosis
  5. 4.1.4 POCT
  6. 4.1.5 Other
  7. 4.2 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type
  8. 4.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Type (2021-2032)
  10. 4.2.3 Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Type (2021-2032)
  11. 4.3 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type
  12. 4.3.1 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Type (2021-2032)
  14. 4.3.3 Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type (2021-2032)
5 In Vitro Diagnostic (IVD) Reagents Market by Application
  1. 5.1 In Vitro Diagnostic (IVD) Reagents Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Other
  5. 5.2 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application
  6. 5.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global In Vitro Diagnostic (IVD) Reagents Sales Volume by Application (2021-2032)
  8. 5.2.3 Global In Vitro Diagnostic (IVD) Reagents Sales Volume Share by Application (2021-2032)
  9. 5.3 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application
  10. 5.3.1 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Application (2021-2032)
  12. 5.3.3 Global In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application (2021-2032)
6 In Vitro Diagnostic (IVD) Reagents Regional Sales and Value Analysis
  1. 6.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global In Vitro Diagnostic (IVD) Reagents Sales by Region (2021-2032)
  3. 6.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2021-2026
  4. 6.2.2 Global In Vitro Diagnostic (IVD) Reagents Sales by Region (2027-2032)
  5. 6.3 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Region (2021-2032)
  7. 6.4.1 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Region: 2021-2026
  8. 6.4.2 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Region (2027-2032)
  9. 6.5 Global In Vitro Diagnostic (IVD) Reagents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032)
  12. 6.6.2 North America In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032)
  15. 6.7.2 Europe In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032)
  21. 6.9.2 South America In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa In Vitro Diagnostic (IVD) Reagents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa In Vitro Diagnostic (IVD) Reagents Sales Value Share by Country, 2025 VS 2032
7 In Vitro Diagnostic (IVD) Reagents Country-level Sales and Value Analysis
  1. 7.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2032)
  4. 7.3.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2026)
  5. 7.3.2 Global In Vitro Diagnostic (IVD) Reagents Sales by Country (2027-2032)
  6. 7.4 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country (2021-2032)
  7. 7.4.1 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country (2021-2026)
  8. 7.4.2 Global In Vitro Diagnostic (IVD) Reagents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt In Vitro Diagnostic (IVD) Reagents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt In Vitro Diagnostic (IVD) Reagents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt In Vitro Diagnostic (IVD) Reagents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche In Vitro Diagnostic (IVD) Reagents Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Danaher
  8. 8.2.1 Danaher Company Information
  9. 8.2.2 Danaher Business Overview
  10. 8.2.3 Danaher In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Danaher In Vitro Diagnostic (IVD) Reagents Product Portfolio
  12. 8.2.5 Danaher Recent Developments
  13. 8.3 Abbott Laboratories
  14. 8.3.1 Abbott Laboratories Company Information
  15. 8.3.2 Abbott Laboratories Business Overview
  16. 8.3.3 Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Product Portfolio
  18. 8.3.5 Abbott Laboratories Recent Developments
  19. 8.4 Thermal Fisher
  20. 8.4.1 Thermal Fisher Company Information
  21. 8.4.2 Thermal Fisher Business Overview
  22. 8.4.3 Thermal Fisher In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Thermal Fisher In Vitro Diagnostic (IVD) Reagents Product Portfolio
  24. 8.4.5 Thermal Fisher Recent Developments
  25. 8.5 Sysmex Corporation
  26. 8.5.1 Sysmex Corporation Company Information
  27. 8.5.2 Sysmex Corporation Business Overview
  28. 8.5.3 Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Product Portfolio
  30. 8.5.5 Sysmex Corporation Recent Developments
  31. 8.6 Biomerieux
  32. 8.6.1 Biomerieux Company Information
  33. 8.6.2 Biomerieux Business Overview
  34. 8.6.3 Biomerieux In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Biomerieux In Vitro Diagnostic (IVD) Reagents Product Portfolio
  36. 8.6.5 Biomerieux Recent Developments
  37. 8.7 Siemens
  38. 8.7.1 Siemens Company Information
  39. 8.7.2 Siemens Business Overview
  40. 8.7.3 Siemens In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Siemens In Vitro Diagnostic (IVD) Reagents Product Portfolio
  42. 8.7.5 Siemens Recent Developments
  43. 8.8 Ortho Clinical Diagnostics
  44. 8.8.1 Ortho Clinical Diagnostics Company Information
  45. 8.8.2 Ortho Clinical Diagnostics Business Overview
  46. 8.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Product Portfolio
  48. 8.8.5 Ortho Clinical Diagnostics Recent Developments
  49. 8.9 BD
  50. 8.9.1 BD Company Information
  51. 8.9.2 BD Business Overview
  52. 8.9.3 BD In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BD In Vitro Diagnostic (IVD) Reagents Product Portfolio
  54. 8.9.5 BD Recent Developments
  55. 8.10 Bio-Rad
  56. 8.10.1 Bio-Rad Company Information
  57. 8.10.2 Bio-Rad Business Overview
  58. 8.10.3 Bio-Rad In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bio-Rad In Vitro Diagnostic (IVD) Reagents Product Portfolio
  60. 8.10.5 Bio-Rad Recent Developments
  61. 8.11 Myriad Genetics
  62. 8.11.1 Myriad Genetics Company Information
  63. 8.11.2 Myriad Genetics Business Overview
  64. 8.11.3 Myriad Genetics In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Myriad Genetics In Vitro Diagnostic (IVD) Reagents Product Portfolio
  66. 8.11.5 Myriad Genetics Recent Developments
  67. 8.12 Hologic
  68. 8.12.1 Hologic Company Information
  69. 8.12.2 Hologic Business Overview
  70. 8.12.3 Hologic In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hologic In Vitro Diagnostic (IVD) Reagents Product Portfolio
  72. 8.12.5 Hologic Recent Developments
  73. 8.13 QIAGEN
  74. 8.13.1 QIAGEN Company Information
  75. 8.13.2 QIAGEN Business Overview
  76. 8.13.3 QIAGEN In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 QIAGEN In Vitro Diagnostic (IVD) Reagents Product Portfolio
  78. 8.13.5 QIAGEN Recent Developments
  79. 8.14 Mindray Medical
  80. 8.14.1 Mindray Medical Company Information
  81. 8.14.2 Mindray Medical Business Overview
  82. 8.14.3 Mindray Medical In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Mindray Medical In Vitro Diagnostic (IVD) Reagents Product Portfolio
  84. 8.14.5 Mindray Medical Recent Developments
  85. 8.15 Wondfo
  86. 8.15.1 Wondfo Company Information
  87. 8.15.2 Wondfo Business Overview
  88. 8.15.3 Wondfo In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Wondfo In Vitro Diagnostic (IVD) Reagents Product Portfolio
  90. 8.15.5 Wondfo Recent Developments
  91. 8.16 KHB
  92. 8.16.1 KHB Company Information
  93. 8.16.2 KHB Business Overview
  94. 8.16.3 KHB In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 KHB In Vitro Diagnostic (IVD) Reagents Product Portfolio
  96. 8.16.5 KHB Recent Developments
  97. 8.17 Da An Gene
  98. 8.17.1 Da An Gene Company Information
  99. 8.17.2 Da An Gene Business Overview
  100. 8.17.3 Da An Gene In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Da An Gene In Vitro Diagnostic (IVD) Reagents Product Portfolio
  102. 8.17.5 Da An Gene Recent Developments
  103. 8.18 Leadman
  104. 8.18.1 Leadman Company Information
  105. 8.18.2 Leadman Business Overview
  106. 8.18.3 Leadman In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Leadman In Vitro Diagnostic (IVD) Reagents Product Portfolio
  108. 8.18.5 Leadman Recent Developments
  109. 8.19 Biosino
  110. 8.19.1 Biosino Company Information
  111. 8.19.2 Biosino Business Overview
  112. 8.19.3 Biosino In Vitro Diagnostic (IVD) Reagents Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Biosino In Vitro Diagnostic (IVD) Reagents Product Portfolio
  114. 8.19.5 Biosino Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 In Vitro Diagnostic (IVD) Reagents Value Chain Analysis
  2. 9.1.1 In Vitro Diagnostic (IVD) Reagents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 In Vitro Diagnostic (IVD) Reagents Sales Mode & Process
  6. 9.2 In Vitro Diagnostic (IVD) Reagents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 In Vitro Diagnostic (IVD) Reagents Distributors
  9. 9.2.3 In Vitro Diagnostic (IVD) Reagents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst